natgillin/translations-raw huggingface dataset:
Feeling unwell (malaise).
Slabo počutje (šibkost).
Feeling unwell or unhappy, slow thinking
plošno slabo počutje ali žalost, počasno razmišljanje
feeling unwell or weak
labo počutje ali šibkost
feeling unwell weight decrease
labo počutje zmanjšanje telesne mase
Feeling unwell.
Slabo počutje.
feeling very sleepy or tired
izrazita zaspanost ali utrujenost
feeling very thirsty
občutek hude žeje
feeling very tired
huda utrujenost
feeling very tired
občutek hude utrujenosti
feeling very tired (fatigue)
huda utrujenost
feeling very tired (fatigue)
občutek hude utrujenosti
Feeling very tired (fatigue)
občutek hude utrujenosti (utrujenost)
feeling very tired (fatigue) falling down.
občutek izčrpanosti (utrujenost) padec
feeling very tired (fatigue) headache
izrazita utrujenost glavobol
feeling very tired or weak
močna utrujenost ali šibkost,
feeling very weak or tired
občutek izredne šibkosti ali utrujenosti
feeling warmth, a pricking or tingling sensation, or pain in an extremity, shoulder, the neck or jaw
občutek vročice, mravljinčenje ali bolečina v okončini, rami, vratu ali čeljusti,
Feeling weak
labo počutje,
feeling weak
občutek slabotnosti,
Feeling weak
občutek šibkosti
feeling weak
občutek šibkosti,
feeling weak (asthenia)
šibkost (astenija),
feeling weak and generally unwell
občutek šibkosti in splošnega slabega počutja
feeling weak and having no energy,
občutek šibkosti in pomanjkanja energije,
Feeling weak and tired
občutek oslabelosti in utrujenosti
Feeling weak and tired
občutek šibkosti in utrujenosti,
feeling weak asthma attacks
občutek šibkosti, napadi astme.
feeling weak general feeling of being unwell
občutek oslabelosti splošno slabo počutje
feeling weak or feeling low in energy
občutek oslabelosti ali občutek pomanjkanja energije;
feeling weak or generally unwell changes in liver function, which will show up in blood tests.
občutek šibkosti ali splošno slabo počutje, spremembe v delovanju jeter; to se pokaže pri preiskavah krvi.
feeling weak or lack of energy (asthenia)
občutek šibkosti ali pomanjkanje energije (astenija)
feeling weak or tired
občutek šibkosti ali utrujenost
Feeling weak or tired
občutek šibkosti ali utrujenosti
feeling weak or tired all the time
občutja nenehne šibkosti in utrujenosti
Feeling weak or tired;
občutek šibkosti ali utrujenosti;
feeling weak, dizzy, tired or sleepy
šibkost, omotičnost, utrujenost ali zaspanost
feeling weak, dizzy, tired, or sleepy
šibkost, omotičnost, utrujenost ali zaspanost
Feeling weak, faint or unsteady, lack of energy or strength, low blood pressure.
labotnost, omedlevica ali nestanovitnost, pomanjkanje energije ali moči, nizek krvni tlak,
feeling weak, feeling tired
občutek šibkosti, občutek utrujenosti
feeling weak, feeling tired
občutek šibkosti, občutek utrujenosti,
feeling weak, generally feeling unwell
občutek šibkosti, splošno slabo počutje
feeling weak, pain or stiff muscles around your body
občutek šibkosti, bolečine ali okorele mišice po telesu,
feeling weak/tired
občutek šibkosti/utrujenosti
feeling weak/tired
občutek šibkosti/utrujenosti,
feeling worried
občutek zaskrbljenosti,
Feeling worried (although this effect occurs mainly in children when prescribed this combination of drugs but in a lower strength).
občutek zaskrbljenosti (čeprav se ta učinek običajno pojavi pri otrocih, ki se jim predpiše ta kombinacija zdravil v manjši jakosti);
feeling worried or depressed
zaskrbljenost ali depresija;
feeling your heart beating fast
občutek hitrega bitja srca,
Feeling your heartbeat
občutek razbijanja srca,
Feeling your heartbeat
razbijanje srca
Feeling your heartbeat (palpitations)
zavedanje lastnega srčnega utripa (palpitacije)
feeling your heartbeat in your chest (palpitations)
razbijanje srca v prsnem košu (palpitacije)
Feeling your own heart beat (palpitations)
občutenje lastnega srčnega utripa (palpitacije)
feeling “high”
vznesenost,
feelings of anxiety
občutek tesnobe
feelings of depression, suicidal thoughts, or notice unusual changes in your behaviour tremors, agitation, confusion, fever, rapid pulse, or wide fluctuations in your blood pressure, or notice that your muscles get very rigid or jerk violently.
občutki depresije, samomorilne misli, ali če opazite nenavadne spremembe v svojem vedenju; tresenje, agitacija, zmedenost, povišana telesna temperatura, hiter srčni utrip ali močna nihanja krvnega tlaka, ali če opazite, da vaše mišice postanejo zelo toge ali da močno trzajo.
feelings of numbness or tingling
občutek odrevenelosti ali mravljincev;
feelings of numbness or tingling,
občutek odrevenelosti ali mravljincev,
feelings of weakness (cancer patients)
občutki šibkosti (bolniki z rakom)
feelings of weakness (chronic renal failure patients)
občutki šibkosti (bolniki s kronično ledvično okvaro)
Felbamate (a medicine used to treat epilepsy) may also affect Fycompa.
Tudi felbamat (zdravilo za zdravljenje epilepsije) lahko vpliva na zdravilo Fycompa.
feline calicivirosis (a flu-like illness with inflammation of the mouth caused by a calicivirus),
kalicivirozi mačk (gripi podobni bolezni z vnetjem ust, ki jo povzroča kalicivirus),
feline calicivirosis (a flu-like illness with inflammation of the mouth caused by a calicivirus), chlamydiosis (a flu-like illness caused by the bacterium C. felis),
kalicivirozi mačk (gripi podobni bolezni z vnetjem ust, ki jo povzroča kalicivirus), klamidiozi (gripi podobni bolezni, ki jo povzroča bakterija C. felis),
feline calicivirosis (a flu-like illness with inflammation of the mouth caused by a calicivirus), chlamydiosis (a flu-like illness caused by the bacterium C. felis), feline panleucopenia (a serious illness causing bloody diarrhoea caused by a parvovirus).
kalicivirozi mačk (gripi podobni bolezni z vnetjem ust, ki jo povzroča kalicivirus), klamidiozi (gripi podobni bolezni, ki jo povzroča bakterija C. felis), panleukopeniji mačk (resni bolezni, ki povzroča krvavo drisko in jo povzroča parvovirus).
feline calicivirosis (a flu-like illness with inflammation of the mouth caused by a calicivirus), chlamydiosis (a flu-like illness caused by the bacterium C. felis).
kalicivirozi mačk (gripi podobni bolezni z vnetjem ust, ki jo povzroča kalicivirus), klamidiozi (gripi podobni bolezni, ki jo povzroča bakterija C. felis).
feline calicivirosis (a flu-like illness with inflammation of the mouth caused by a calicivirus), feline panleucopenia (a serious illness causing bloody diarrhoea caused by a parvovirus).
kalicivirozi mačk (gripi podobni bolezni z vnetjem ust, ki jo povzroča kalicivirus), mačji panlevkopeniji (resni bolezni, ki povzroča krvavo drisko in jo povzroča parvovirus).
feline calicivirosis (a flu-like illness with inflammation of the mouth caused by a calicivirus);
kalicivirozi mačk (gripi podobni bolezni z vnetjem ust, ki jo povzroča kalicivirus);
feline calicivirosis to reduce clinical signs,
kalicivirozi mačk za zmanjšanje kliničnih znakov
feline calicivirosis to reduce clinical signs,
kalicivirozi mačk za zmanjšanje kliničnih znakov,
Feline interleukin-2 recombinant canarypox virus (vCP1338) ....................................... ≥ 106.0 EAID*50
Rekombinantni pox virus kanarčkov (vCP1338), ki vsebuje mačji interleukin-2............ ≥ 106.0 EAID*50
Feline interleukin-2 recombinant canarypox virus (vCP1338) ........................................≥ 106.0 EAID50
Rekombinantni pox virus kanarčkov (vCP1338), ki vsebuje mačji interleukin-2.............. ≥ 106.0 EAID50
feline panleucopenia (a serious illness causing bloody diarrhoea caused by a parvovirus), feline leukaemia (an illness affecting the immune system caused by a retrovirus).
panleukopeniji mačk (resni bolezni, ki povzroča krvavo drisko in jo povzroča parvovirus), mačji levkemiji (bolezni, ki prizadene imunski sistem in jo povzroča retrovirus).
feline panleucopenia (a serious illness causing bloody diarrhoea caused by a parvovirus); feline leukaemia (an illness affecting the immune system caused by a retrovirus).
mačji panlevkopeniji (resni bolezni, ki povzroča krvavo drisko in jo povzroča parvovirus); mačji levkemiji (bolezni, ki prizadene imunski sistem in jo povzroča retrovirus).
feline viral rhinotracheitis (a flu-like illness caused by a herpesvirus),
virusnemu rinotraheitisu mačk (gripi podobni bolezni, ki jo povzroča herpesvirus),
feline viral rhinotracheitis (a flu-like illness caused by a herpesvirus), feline calicivirosis (a flu-like illness with inflammation of the mouth caused by a calicivirus).
virusnemu rinotraheitisu mačk (gripi podobni bolezni, ki jo povzroča herpesvirus), kalicivirozi mačk (gripi podobni bolezni z vnetjem ust, ki jo povzroča kalicivirus).
feline viral rhinotracheitis (a flu-like illness caused by a herpesvirus);
virusnemu rinotraheitisu mačk (gripi podobni bolezni, ki jo povzroča virus herpesa);
felis (905 strain): at least 3.0 log 10
905): ≥ 103,0 EID50 na odmerek
felodipine
ANTAGONISTI CCR5
Felodipine
nikardipin
Felodipine, Nifedipine,
Midazolam
Felodipine, Nifedipine,
Peroralni midazolam:
Felodipine, Nifedipine, and
je upoštevati, da odmerek rifabutina
Felodipine, Nifedipine, Nicardipine:
rifamicin in k neuspešnemu zdravljenju.
felodipine, nisoldipine due to an increased risk of oedema and congestive heart failure
felodipin, nizoldipin zaradi povečanega tveganja edema in kongestivnega srčnega popuščanja,
FeLV recombinant canarypox virus
kanarčkov, ki vsebuje antigen virusa
FeLV recombinant canarypox virus
Rekombinantni poxvirus kanarčkov, ki
FeLV recombinant canarypox virus (vCP97) ..................................................................  107.2 CCID 1
Rekombinantni poxvirus kanarčkov ki vsebuje antigen virusa mečje levkemije(vCP97)  107,2 CCID 1
FeLV recombinant canarypox virus (vCP97) ..................................................................  107.2 CCID 1
Rekombinantni poxvirus kanarčkov, ki vsebuje antigen virusa mačje levkemije (vCP97) .............................................................................................................................  107,2 CCID 1
Female
ženske
Female (72%) and male (28%) patients with a mean age of 59 years (range 18 – 95 years) were included.
Študije so zajele bolnice (72 %) in bolnike (28 %) s povprečno starostjo 59 let (razpon: od 18 do 95 let).
Female and male patients of reproductive potential must be made aware of the increased risk of pregnancy loss and congenital malformations at the beginning of the treatment and must be counseled regarding pregnancy prevention, and planning.
Bolnice v rodni dobi in bolniki, zmožni reprodukcije, se morajo zavedati, da obstaja večje tveganje za izgubo nosečnosti in kongenitalne malformacije na začetku zdravljenja.
Female and male patients of reproductive potential should be made aware of the risks and follow the recommendations provided in section 4.6 (e.g. contraceptive methods, pregnancy testing) prior to, during, and after therapy with mycophenolate.
Bolnice in bolniki, zmožni reprodukcije, se morajo zavedati tveganj in upoštevati priporočila iz poglavja 4.6 (npr. glede kontracepcijskih metod, preverjanja nosečnosti) pred, med in po zdravljenju z mofetilmikofenolatom.
Female and male patients of reproductive potential should be made aware of the risks and follow the recommendations provided in section 4.6. (e.g. contraceptive methods, pregnancy testing) prior to, during, and after therapy with CellCept.
Bolnice in bolniki, zmožni reprodukcije, se morajo zavedati tveganj in upoštevati priporočila iz poglavja 4.6 (npr. glede kontracepcijskih metod, preverjanja nosečnosti) pred, med in po zdravljenju z zdravilom CellCept.
Female and male patients of reproductive potential should be made aware of the risks and follow the recommendations provided in section 4.6. (e.g. contraceptive methods, pregnancy testing) prior to, during, and after therapy with Myclausen.
Bolnice in bolniki, zmožni reprodukcije, se morajo zavedati tveganj in upoštevati priporočila iz poglavja 4.6 (npr. glede kontracepcijskih metod, preverjanja nosečnosti) pred, med in po zdravljenju z zdravilom Myclausen.
Female fertility is likely to be compromised during treatment with ramucirumab based on studies in animals (see section 5.3).
Na podlagi študij pri živalih je verjetno, da bo plodnost žensk med zdravljenjem z ramucirumabom slabša (glejte poglavje 5.3).
Female gender
Ženske bolnice
Female gender and higher CD4 counts (>250/mm3 in adult females and >400/mm3 in adult males) at the initiation of nevirapine therapy are associated with a greater risk of hepatic adverse reactions if the patient has detectable plasma HIV-1 RNA - i.e. a concentration ≥ 50 copies/ml - at the initiation of nevirapine.
Pri ženskah in bolnikih z večjim številom celic CD4 (> 250/mm3 pri odraslih ženskah in > 400/mm3 pri odraslih moških) je na začetku zdravljenja z nevirapinom povečano tveganje neželenih učinkov na jetra, če imajo v plazmi izmerljivo raven HIV-1 RNA – tj. če je ob uvajanju nevirapina koncentracija ≥ 50 kopij/ml.
Female gender and higher CD4 counts (>250/mm3 in adult females and >400/mm3 in adult males) at the initiation of nevirapine therapy are associated with a greater risk of hepatic adverse reactions if the patient has detectable plasma HIV-1 RNA - i.e. a concentration ≥ 50 copies/ml - at the initiation of nevirapine.
Pri ženskah in bolnikih z večjim številom celic CD4 (> 250/mm3 pri odraslih ženskah in > 400/mm3 pri odraslih moških) na začetku zdravljenja z nevirapinom povečano tveganje neželenih učinkov na jetra, če imajo v plazmi izmerljivo raven HIV-1 RNA – tj. če je ob uvajanju nevirapina koncentracija ≥ 50 kopij/ml.
Female gender, lower body weight, and underlying renal impairment
Ženski spol, manjša telesna masa in obstoječa ledvična okvara
Female mice receiving duloxetine for 2 years had an increased incidence of hepatocellular adenomas and carcinomas at the high dose only (144 mg/kg/day), but these were considered to be secondary to hepatic microsomal enzyme induction.
Mišje samice, ki so prejemale duloksetin 2 leti, so imele povišano incidenco hepatocelularnih adenomov in karcinomov samo pri visokem odmerku (144 mg/kg/dan), vendar za te velja, da se pojavijo sekundarno zaradi indukcije jetrnih mikrosomskih encimov.
Female partners of male patients must have a routine pregnancy test performed monthly during treatment and for seven months thereafter (see section 4.6).
Partnerke bolnikov morajo rutinsko opravljati nosečnostni test vsak mesec med zdravljenjem in še sedem mesecev po njem (glejte poglavje 4.6).
Female partners of male patients must have a routine pregnancy test performed monthly during treatment and for seven months thereafter (see section 4.6).
Partnerke bolnikov morajo rutinsko opravljati test nosečnosti vsak mesec med zdravljenjem in še sedem mesecev po njem (glejte poglavje 4.6).
Female patient of childbearing potential
bolnica v rodni dobi
Female patient of childbearing potential
bolnica v rodni dobi;
Female patients
Bolnice
Female patients had a 15% higher plasma exposure (AUCτ,ss, body weight corrected) than male patients.
Pri ženskah je bila plazemska izpostavljenost za 15% večja (AUCτ,ss, popravljeno za telesno maso) kot pri moških.
Female patients Male patients
Bolnice Bolniki
Female patients must have a routine pregnancy test performed monthly during treatment and for four months thereafter.
Bolnice morajo rutinsko opravljati test nosečnosti vsak mesec med zdravljenjem in še štiri mesece po njem.
Female patients must use two methods of recommended contraception including one highly effective method and a barrier method during Erivedge therapy and for 24 months after the final dose (see section 4.6).
Ženske bolnice morajo uporabljati dva priporočena načina kontracepcije (to obsega en visokoučinkovit način in en pregradni način) med zdravljenjem z zdravilom Erivedge in še 24 mesecev po zadnjem odmerku tega zdravila (glejte poglavje 4.6).
Female patients of childbearing age and their male partners
Bolnice v rodni dobi in njihovi partnerji
Female patients of childbearing potential should use either a hormonal contraceptive containing at least 30 µg ethinylestradiol and containing norgestimate as the progestagen or should use an alternative reliable method of contraception (see sections 4.5 and 4.6).
Bolnice v rodni dobi morajo uporabljati bodisi hormonsko kontracepcijo, ki vsebuje vsaj 30 µg etinilestradiola in ki vsebuje norgestimat kot progestagen, ali pa morajo uporabljati alternativno zanesljivo metodo kontracepcije (glejte poglavji 4.5 in 4.6).
Female patients should use adequate contraception as fertility may be increased.
Ženske bolnice morajo uporabljati ustrezno kontracepcijo, ker je plodnost lahko povečana.
Female patients: Women of childbearing potential should not receive ribavirin unless they are using an effective form of contraception during treatment with ribavirin and for 4 months after treatment.
Bolnice: Ženske v rodni dobi ne smejo dobivati ribavirina, če med zdravljenjem z ribavirinom in še 4 mesece po zdravljenju ne uporabljajo učinkovite oblike kontracepcije.
Female rats were administered daily dosages of 0.3 to 30 mg/kg (0.15 to 14.6 times the human dose based on body surface area, mg /m2 [20 mg/kg dosage in humans is 12.3 mg/m2]) prior to and during mating with untreated males.
Samicam podgan so dajali dnevne odmerke od 0,3 do 30 mg/kg (0,15- do 14,6-kratni odmerek pri človeku glede na telesno površino, mg /m2 [odmerek 20 mg/kg pri človeku je 12,3 mg/m2]) pred parjenjem s samci, ki niso prejemali zdravila, in po njem.
Female salmonid fish such as Atlantic salmon (Salmo salar), rainbow trout (Oncorhynchus mykiss), brown trout (Salmo trutta) and Arctic charr (Salvelinus alpinus).
Plemenke salmonidnih rib, kot so atlantski losos (Salmo salar), kalifornijska postrv ali šarenka (Oncorhynchus mykiss), rjava postrv (Salmo trutta) in jezerska zlatovčica (Salvelinus alpinus)
Female: amenorrhea, menorrhagia, menstrual disorder, vaginal disorder, Male: testicular pain
Ženske: amenoreja, menoragija, menstrualne motnje, bolezni nožnice, Moški: bolečine v testisih
females
ženskah,
Females
ženski spol
Females of child-bearing age should take the necessary precautions to avoid pregnancy for 1 month, or according to doctor’s recommendation, after they have been given the vaccine.
Ženske v rodni dobi morajo 1 mesec po cepljenju, oziroma po navodilu zdravnika, ustrezno poskrbeti, da ne zanosijo.
Females were not studied in nmDMD clinical trials.
Žensk v kliničnih preskušanjih pri bolnikih z DMD zaradi nesmiselne mutacije niso proučevali.
Females were observed with increased embryonic resorptions, and decreases in implantations and viable embryos.
Pri samicah so opazili povečanje resorpcije zarodkov, zmanjšanje števila implantacij in zarodkov, sposobnih za življenje.
Femoral artery thrombosis Capillary leak syndrome
femoralna arterijska tromboza sindrom kapilarnega prepuščanja
femoral fractures† (bisphosphonate class
in zlomi diafize stegnenice† (za
Femoral neck BMD
MKG femoralnega vratu
Femoral neck BMD
MKG stegneničnega vratu
Fenbendazole is effective and has a dose dependent effect on adult and immature stages.
Febendazol je učinkovit in ima od odmerka odvisen učinek proti odraslim in nezrelim stadijem.
Fendrix contains two things called “MPL” (a non-toxic purified fat derivative from bacteria) and “aluminium phosphate”.
Cepivo Fendrix vsebuje dve sestavini: ena se imenuje "MPL" (to je nestrupen, prečiščen maščobni izvleček bakterij), druga pa "aluminijev fosfat".
Fendrix has moderate influence on the ability to drive and use machine.
Cepivo Fendrix ima zmeren vpliv na sposobnost vožnje in upravljanja s stroji.
Fendrix helps your body to produce its own protection against the virus (antibodies).
Cepivo Fendrix telesu pomaga ustvariti lastno zaščito proti virusu (protitelesa).
Fendrix is a vaccine which prevents hepatitis B. It is used for patients with kidney problems:
Fendrix je cepivo, ki se uporablja za preprečevanje hepatitisa B. Uporablja se za bolnike, ki imajo težave z ledvicami:
Fendrix is a white, milky suspension presented in a glass prefilled syringe (0.5 ml).
Cepivo Fendrix je bela, mlečna suspenzija v stekleni napolnjeni injekcijski brizgi (0,5 ml).
Fendrix is available in packs of 1 (with or without a separate needle) and in a pack size of 10 without needles.
Cepivo Fendrix je na voljo v pakiranjih z 1 napolnjeno injekcijsko brizgo (z ločeno iglo ali brez nje) in v pakiranjih z 10 napolnjenimi injekcijskimi brizgami brez igel.
Fendrix is indicated in adolescents and adults from the age of 15 years onwards for active immunisation against hepatitis B virus infection (HBV) caused by all known subtypes for patients with renal insufficiency (including pre-haemodialysis and haemodialysis patients).
Cepivo Fendrix je indicirano pri mladostnikih in odraslih, starejših od 15 let, za aktivno imunizacijo bolnikov z ledvično insuficienco (vključno s predhemodializnimi in hemodializnimi bolniki) proti okužbi z vsemi znanimi podtipi virusa hepatitisa B (HBV).
Fendrix may not protect you from being ill if you have already caught the hepatitis B virus.
Cepivo Fendrix vas morda ne bo zaščitilo pred boleznijo, če ste že okuženi z virusom hepatitisa B.
Fendrix should not be given if any of the above apply to you.
Če kaj od naštetega velja za vas, ne smete prejeti cepiva Fendrix.
Fendrix suspension for injection
Fendrix suspenzija za injiciranje
Fendrix suspension for injection IM
Fendrix suspenzija za injiciranje i.m.
fenfluramine (to reduce weight) tritoqualine (to treat allergies)
fenfluramin (za zmanjšanje telesne mase) tritokvalin (za zdravljenje alergij)
fenfluramine, pentoxifylline (high dose parenteral), fibrates, tritoqualine,
fenfluramin, pentoksifilin (velik parenteralen odmerek),
Fenofibrate and simvastatin are not CYP 3A4 inhibitors or inducers.
Fenofibrat in simvastatin nista zaviralca ali induktorja CYP 3A4.
Fenofibrate has a uricosuric effect and is therefore of additional benefit in such patients.
Fenofibrat ima urikozurični učinek in zato takim bolnikom dodatno koristi.
Fenofibrate is a ‘PPAR agonist’.
Fenofibrat je „agonist PPAR“.
Fenofibrate is a ‘PPAR agonist’.
Fenofibrat je „agonist receptorja PPAR“.
Fenofibric acid is strongly bound to plasma albumin (more than 99%).
Fenofibratna kislina je močno vezana na plazemske albumine (več kot 99-odstotno).
Fentanyl 50 mg/ml
Fentanil 50 mg/l
Fentanyl can pass into the breast milk and may cause side effects to the breast-fed child.
Fentanil lahko preide v materino mleko in povzroči neželene učinke pri dojenčku.
Fentanyl citrate concentrations obtained in serum were higher than in plasma: Serum AUC and Cmax were approximately 20% and 30% higher than plasma AUC and Cmax, respectively.
Koncentracije fentanil citrata v serumu so bile višje kot v plazmi: AUC v serumu je bil približno 20 % višji in Cmax v serumu približno 30 % višji, kot sta AUC in Cmax v plazmi.
Fentanyl diffuses from the gel and is absorbed through the nasal mucosa; this gel-modulated absorption of fentanyl restrains the peak in plasma concentration (Cmax) whilst allowing the attainment of an early time to that peak (Tmax).
Fentanil difundira iz gela in se absorbira skozi nosno sluznico; ta z gelom modulirana absorpcija fentanila zniža vrh plazemske koncentracije (Cmax), hkrati pa omogoči, da se ta vrh hitro doseže (Tmax).
Fentanyl gradually moves through the skin into your dog’s bloodstream and then relieves pain.
Fentanil počasi potuje skozi kožo v krvni obtok psa in potem lajša bolečine.
Fentanyl has a well-known abuse potential.
Potencial zlorabe fentanila je zelo znan.
Fentanyl is absorbed quickly through the lining of your nose and into the blood stream.
Fentanil se hitro absorbira skozi vašo nosno sluznico v krvni obtok.
Fentanyl is an opioid analgesic, interacting predominantly with the opioid µ-receptor.
Fentanil je opioidni analgetik, ki medsebojno deluje pretežno z opioidnim receptorjem µ.
Fentanyl is an opioid analgesic, interacting predominantly with the opioid µ-receptor.
Fentanil je opioidni analgetik, ki pretežno vzajemno deluje z opioidnim µ-receptorjem.
Fentanyl may reduce midazolam clearance.
Fentanil lahko zmanjša očistek midazolama.
Fentanyl passes into breast milk and may cause sedation and respiratory depression in the breast-fed child.
Fentanil prehaja v materino mleko in lahko povzroči sedacijo in depresijo dihanja pri dojenem otroku.